Product/Composition:- | Granisetron Hydrochloride |
---|---|
Strength:- | Injection: 1 mg/mL, 3 mg/3 mL; Oral Tablet : 1 mg |
Form:- | Injection (IV/SC), Oral Tablet |
Reference Brands:- | Kytril® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Granisetron Hydrochloride is an FDA- and EMA-approved antiemetic used in oncology to prevent chemotherapy- and radiation-induced nausea and vomiting. It is widely used in hospitals and cancer centers. B2B buyers in the US and EU can source Granisetron from certified pharmaceutical wholesalers with GMP compliance and reliable supply.
Granisetron Hydrochloride is a trusted antiemetic used in oncology to prevent nausea and vomiting caused by chemotherapy and radiation. Available in 1 mg tablets, 1 mg/mL injections, and transdermal patches (Sancuso®), it plays a critical role in supportive cancer care. Approved by the FDA and EMA, Granisetron is supplied by certified pharmaceutical wholesalers across the US and EU. Hospitals, oncology centers, and infusion clinics rely on this 5-HT3 antagonist for effective patient management. B2B buyers can source Granisetron in bulk with GMP-compliant quality, competitive pricing, and reliable delivery through licensed pharma distributors.